🇺🇸 FDA
Pipeline program

Faster Aspart

NN1218-4316

Phase 1 small_molecule completed

Quick answer

Faster Aspart for Diabetes Mellitus, Type 1 is a Phase 1 program (small_molecule) at Novo Nordisk A/S with 1 ClinicalTrials.gov record(s).

Program details

Company
Novo Nordisk A/S
Indication
Diabetes Mellitus, Type 1
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials